Literature DB >> 8298193

Regulated expression of the human beta globin gene in transgenic mice requires an upstream globin or nonglobin promoter.

K P Anderson1, J A Lloyd, E Ponce, S C Crable, J C Neumann, J B Lingrel.   

Abstract

Transgenic mice have been used extensively to study elements governing the erythroid-specific developmental switch from human fetal gamma to human adult beta globin. Previous work demonstrated that a small construct composed of hypersensitive site 2 (HS2) of the locus control region (LCR) linked to the gamma and beta globin genes (HS2-gamma-beta) is sufficient for correct tissue and temporal expression of these genes, whereas HS2-beta alone is inappropriately expressed in the embryo. Two models, which are not mutually exclusive, have been proposed to explain these results and those of other constructs in transgenic mice. One model emphasizes the conserved polarity in the globin locus and suggests a distance effect whereby the beta globin gene must be removed from the LCR/HS2 to prevent an early and incorrect activation of this gene in the embryonic compartment. A second hypothesis proposes a competition between the gamma and beta globin gene promoters for interaction with the LCR/HS2. The active gamma globin gene promoter positioned between the LCR/HS2 and the beta globin gene thereby interacts with the HS2 elements early in erythroid development and is expressed until a change in putative stage-specific nuclear factors makes an interaction with the adult beta globin gene more favorable. In an effort to test the competition model, a construct has been prepared in which a small deletion was produced in the promoter region of the gamma globin gene while in the context of the HS2-gamma-beta plasmid. Analysis of this construct in transgenic mice reveals a constitutive unregulated expression of the human beta globin gene during erythroid development. To determine if this competition effect is specific for globin genes, a heterologous reporter gene has been substituted for the gamma globin gene in the construct HS2-gamma-beta. In this case, the beta globin gene exhibits correct developmental expression. This data is consistent with a model in which transcription from a promoter upstream of the beta globin gene in some manner protects this adult gene from activation by the LCR/HS2 during early development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8298193      PMCID: PMC275740          DOI: 10.1091/mbc.4.10.1077

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  29 in total

1.  A developmentally stable chromatin structure in the human beta-globin gene cluster.

Authors:  W C Forrester; C Thompson; J T Elder; M Groudine
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

2.  Developmental regulation of human globin genes in transgenic mice.

Authors:  F Costantini; G Radice; J Magram; G Stamatoyannopoulos; T Papayannopoulou; K Chada
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1985

3.  The "beta-like-globin" gene domain in human erythroid cells.

Authors:  D Tuan; W Solomon; Q Li; I M London
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

4.  G gamma beta+ hereditary persistence of fetal hemoglobin: cosmid cloning and identification of a specific mutation 5' to the G gamma gene.

Authors:  F S Collins; C J Stoeckert; G R Serjeant; B G Forget; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

5.  Analysis of transcriptional regulatory signals of the HSV thymidine kinase gene: identification of an upstream control region.

Authors:  S L McKnight; E R Gavis; R Kingsbury; R Axel
Journal:  Cell       Date:  1981-08       Impact factor: 41.582

Review 6.  The molecular genetics of human hemoglobin.

Authors:  F S Collins; S M Weissman
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1984

7.  The human beta-globin gene contains a downstream developmental specific enhancer.

Authors:  G Kollias; J Hurst; E deBoer; F Grosveld
Journal:  Nucleic Acids Res       Date:  1987-07-24       Impact factor: 16.971

8.  An embryonic pattern of expression of a human fetal globin gene in transgenic mice.

Authors:  K Chada; J Magram; F Costantini
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

9.  Identification of a stage selector element in the human gamma-globin gene promoter that fosters preferential interaction with the 5' HS2 enhancer when in competition with the beta-promoter.

Authors:  S M Jane; P A Ney; E F Vanin; D L Gumucio; A W Nienhuis
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

10.  Erythroid-specific expression of human beta-globin genes in transgenic mice.

Authors:  T M Townes; J B Lingrel; H Y Chen; R L Brinster; R D Palmiter
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

View more
  5 in total

1.  Induction of human fetal globin gene expression by a novel erythroid factor, NF-E4.

Authors:  W Zhou; D R Clouston; X Wang; L Cerruti; J M Cunningham; S M Jane
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

2.  Analysis of developmental switching in transgenic mice with 5' and 3' deletions in the human beta globin gene.

Authors:  K P Anderson; C B Kern; S C Crable; J C Neumann; J B Lingrel
Journal:  Transgenic Res       Date:  1996-07       Impact factor: 2.788

3.  Human gamma-globin gene promoter element regulates human beta-globin gene developmental specificity.

Authors:  T M Ryan; C W Sun; J Ren; T M Townes
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

4.  Substitution of the human beta-spectrin promoter for the human agamma-globin promoter prevents silencing of a linked human beta-globin gene in transgenic mice.

Authors:  D E Sabatino; A P Cline; P G Gallagher; L J Garrett; G Stamatoyannopoulos; B G Forget; D M Bodine
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

5.  Evidence for a bigenic chromatin subdomain in regulation of the fetal-to-adult hemoglobin switch.

Authors:  Hugues Beauchemin; Marie Trudel
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.